Tumor progression in the human melanocytic system.
The isolation and routine tissue culture of melanocytic cells from normal skin, precursor nevi, primary and metastatic melanomas has allowed the experimental study of different stages of tumor progression. Characteristic differences between cultured normal melanocytes and highly malignant metastatic melanoma cells were: 1) limited life span for normal melanocytes and non-malignant nevus cells versus infinite growth for malignant melanoma cells; 2) inability to grow anchorage-independently versus high colony forming-efficiency in soft agar; 3) non-tumorigenicity versus tumorigenicity in athymic nude mice; 4) dependence on exogenous growth factors and other mitogens versus autonomous growth in protein-free medium; 5) expression of melanocyte-associated antigens versus expression of melanoma-associated antigens; and 6) diploid karyotype versus non-random chromosomal abnormalities. The only major distinction found between advanced primary and metastatic melanomas was that only metastatic melanoma cells proliferated continuously in the absence of growth factors or other proteins. However, advanced primary melanoma cells could be clearly distinguished from dysplastic nevus cells by their growth behavior and growth factor requirements. Only limited information is available on the biologic, genetic, immunologic and molecular properties of dysplastic nevus cells and early (radial growth phase) primary melanoma cells but these cells appear to differ markedly from advanced primary and metastatic cells. The availability of cells from sequential steps of tumor progression in the human melanocytic system offers a unique experimental model for the study of malignant transformation.
Kath
R
R
Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Rodeck
U
U
Menssen
H D
HD
Mancianti
M L
ML
Linnenbach
A J
AJ
Elder
D E
DE
Herlyn
M
M
D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D005796:Genes; D006133:Growth Substances / Q000235:genetics; D006801:Humans; D008544:Melanocytes / Q000166:cytology / Q000473:pathology*; D008545:Melanoma / Q000235:genetics / Q000473:pathology*; D051379:Mice; D009362:Neoplasm Metastasis; D009506:Nevus / Q000473:pathology; D011493:Protein Kinase C / Q000235:genetics; D011519:Proto-Oncogenes; D011956:Receptors, Cell Surface / Q000235:genetics; D012867:Skin / Q000166:cytology / Q000473:pathology; D012878:Skin Neoplasms / Q000235:genetics / Q000473:pathology*; D014407:Tumor Cells, Cultured / Q000166:cytology
D006133:Growth Substances; D011956:Receptors, Cell Surface; D011493:Protein Kinase C